Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07661433 · ClinicalTrials.gov registry record
Prospective Evaluation of an AI Diagnostic Ultrasound Tool for Fetal Weight Estimation
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Recruiting
- Registry status
- 1,000
- Enrollment target
NCT07661433: Recruiting study, sponsored by University of North Carolina, Chapel Hill.
NCT07661433 is a clinical trial that is actively recruiting participants, run by University of North Carolina, Chapel Hill. The registered enrollment target is 1,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07661433 is actively recruiting participants, sponsored by University of North Carolina, Chapel Hill.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
Purpose: The primary objective of this study is to assess the diagnostic accuracy of an AI-enabled ultrasound tool for estimating fetal weight Participants: 1,000 pregnant individuals Procedures (methods): This prospective diagnostic accuracy study will enroll 1,000 pregnant individuals within one week of anticipated delivery. At a single visit, each participant will undergo two ultrasound assessments: (1) standardized sweeps for AI analysis (performed by both specialist and nonspecialist users), (2) specialist-performed fetal biometry.
Primary Outcome
Mean of pairwise differences in absolute percent error between the AI diagnostic tool (index test) and specialist biometry (clinical reference standard), compared against actual birthweight (ground truth).
Interventions
- DIAGNOSTIC_TEST AI ultrasound diagnostic tool for fetal weight estimation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2026-06-29 |
| Est. Completion | 2026-12 |
What NCT07661433 shows while recruiting
NCT07661433 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which AI ultrasound diagnostic tool for fetal weight estimation is the first listed.
NCT07661433 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07661433 about?
NCT07661433 is a clinical study titled "Prospective Evaluation of an AI Diagnostic Ultrasound Tool for Fetal Weight Estimation". Purpose: The primary objective of this study is to assess the diagnostic accuracy of an AI-enabled ultrasound tool for estimating fetal weight Participants: 1,000 pregnant individuals Procedures (methods): This prospective diagnostic accuracy study will enroll 1,000 pregnant individuals within one w...
What is the current status of trial NCT07661433?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2026-06-29. Estimated completion is 2026-12.
What interventions are being tested in trial NCT07661433?
The interventions under investigation include: AI ultrasound diagnostic tool for fetal weight estimation (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07661433?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI